dimyristoylphosphatidylcholine has been researched along with Acute Lymphoid Leukemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ichihara, H; Kuwabara, K; Kuwano, M; Matsumoto, Y | 1 |
Ichihara, H; Matsumoto, Y; Ueno, J; Ueoka, R; Umebayashi, M | 1 |
2 other study(ies) available for dimyristoylphosphatidylcholine and Acute Lymphoid Leukemia
Article | Year |
---|---|
Therapeutic effects of trehalose liposomes against lymphoblastic leukemia leading to apoptosis in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Dimyristoylphosphatidylcholine; Enzyme Activators; Glycolipids; Humans; Liposomes; Membrane Fluidity; Membrane Microdomains; Membrane Potentials; Mice; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Xenograft Model Antitumor Assays | 2016 |
Chemotherapy with hybrid liposomes for acute lymphatic leukemia leading to apoptosis in vivo.
Topics: Animals; Apoptosis; Cell Culture Techniques; Cell Line, Tumor; Dimyristoylphosphatidylcholine; Female; Humans; In Situ Nick-End Labeling; Liposomes; Membrane Potential, Mitochondrial; Mice; Mice, SCID; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Analysis; Xenograft Model Antitumor Assays | 2011 |